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Abstract
PURPOSE: The goals of this study were to: improve delirium recognition by implementing the
Confusion Assessment Method for the ICU (CAM-ICU), evaluate adherence to routine delirium
monitoring, measure the incidence of CAM-positive patients, and measure the use of analgesic
and sedative medications in ICU patients.
METHODS: This study was a single-center post-implementation retrospective medical record
review examining the adherence and incidence of delirium after the introduction of the CAMICU assessment on the surgical ICU. Prior to the beginning of the study the surgical ICU nurses
were educated on how to assess for delirium using the CAM-ICU instrument. During the six
week study the following data were collected: adherence to delirium monitoring through
documentation, incidence of CAM-positive patients, and sedation and analgesic medication
usage. The sample consisted of seventy-six patients that were admitted to the surgical ICU
between September 6, 2016 and October 18, 2016.
RESULTS: Thirty-two (58.1%) patients had the CAM-ICU assessment completed once a shift
at the 48-hour evaluation and twenty-two (81.4%) patients during the 96-hour evaluation. Five
(9%) patients were CAM-positive at the 48-hour and one (3.7%) at the 96-hour evaluation. The
48-hour time interval had the highest average number of dosages for analgesic medications at 2.3
(29.4%) for CAM-negative patients. CAM-positive analgesic medications usage increased
progressively, peaking at the 72-hour interval with the average dose at 3.6 (32.1%). With regards
to sedative medications, CAM-negative patients had the highest average number of dosages, 1.9
(30.2%), at the 48-hour interval. For CAM-positive patients the use of sedative medications
peaked at the 24-hour interval and then decreased at the 48-hour time frame; after which sedative
medication usage rose steadily from the 48 through 96-hour interval.
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CONCLUSION: Required routine delirium monitoring should occur per evidence-based
practice guidelines for all ICU patients. The incidence of delirium in this study was found to be
low, at 9%, when compared to previous studies on delirium. No statistically significant
conclusions could be drawn from this study. Factors that could have contributed to this low
incidence of delirium in these specific patients could have been the relative young age of the
patients (mean age of 53.2) and the possible lower severity of illness, both of these factors
influence the risk of delirium development. In conclusion, this single study may have found a
low incidence of delirium among these specific ICU patients but many previous studies have
determined that the incidence of delirium is much higher.
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Monitoring for Delirium in the Intensive Care Unit Following the Introduction of the Confusion
Assessment Method for the Intensive Care Unit
Introduction
As the population ages, more people will require treatment of acute conditions in the
hospital. This increased encounter of the aging population with a more intensive treatment of
medical problems is believed to result in an increase in the prevalence of delirium among this
population (Angus, Kelley, Schmitz, White, & Popovich, 2000). One of the major objectives for
improvement in the quality of care for the aging adult population is the improvement of
recognizing, treating and preventing delirium (Vincent et al., 1998). This objective was identified
almost twenty years ago but delirium still remains an enormous issue that is often not recognized
and treated within the health care system (Barr et al., 2013). Pandharipande, Jackson, and Ely
(2005) identified a high incidence of delirium among intensive care unit (ICU) patients. Current
evidence-based practice recommends routine delirium monitoring using a valid and reliable
diagnostic tool once a shift (every twelve hours) for all ICU patients (Barr et al., 2013).
Therefore, the goals of this study were to: improve delirium recognition by implementing the
Confusion Assessment Method for the ICU (CAM-ICU), evaluate adherence to routine delirium
monitoring, measure the incidence of CAM-positive patients, and measure the use of analgesic
and sedative medications in ICU patients (see figure 1 for CAM-ICU assessment flowsheet).
Background
Delirium is defined as an “acute, fluctuating change in mental status, with inattention and
altered level of consciousness” (Pandharipande et al., 2005, p. 360). In the past this condition
was viewed as a normal occurrence brought about by the ICU environment, which resulted in
providers failing to recognize delirium as a serious medical diagnosis (Pandharipande et al.,
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2005). This study also concluded that “delirium is not only a marker of end-organ damage but
also acts directly as a promoter of other organ systems dysfunctions” (p. 360). The typical ICU
patient has 10 or more risk factors, e.g. age, severity of illness, and the use of
sedatives/analgesics medications, for the development of delirium (Pandharipande et al., 2006).
Delirium is unrecognized in up to 66% of ICU patients and has an estimated incidence up
to 80% (Arend & Christensen, 2009; Pandharipande et al., 2005). These studies found that a
failure to recognize and/or treat delirium appropriately in the ICU has led to negative patient
outcomes. Specifically, Pandharipande et al. (2005) found an “increased mortality of 25 to 33%
and a three times greater risk of discharge to a nursing home” (p. 363). While increased medical
costs, a 49% increased length of stay (LOS) compared to non-delirious patents, and increased
stress for family members and medical staff have also been linked to delirium (Arend &
Christensen, 2009; Robinson et al., 2008).
Pandharipande et al. (2006) point out, patients are commonly being prescribed a
benzodiazepine, like Lorazepam, which has been linked to further exacerbation of delirium. This
study included 198 ICU patients and found that “Lorazepam was an independent risk factor for
daily transition to delirium” and “the probability of the transition to delirium is 100%”, when
20mg or more is given in a 24-hour period (p.23). Additionally, this study investigated Versed,
Morphine, Fentanyl and Propofol all of which were associated with delirium development but
the findings were not statistically significant like Lorazepam.
A key factor in improving delirium recognition is engagement of nurses and providers to
routinely monitor for delirium using a reliable and valid bedside diagnostic instrument
(Pandharipande et al., 2005). The Society of Critical Care Medicine recommends the use of the
CAM-ICU because it is the most specific and reliable diagnostic instrument, with a specificity of
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96% and sensitivity of 80% (Gusmao-Flores, Figueira Salluh, Chalhub, & Quarantini, 2012;
Luetz et al., 2010; Olson, 2012). However, Eastwood, Peck, Bellomo, Baldwin, and Reade
(2012) found that only 20% of ICU nurses knew that there was a diagnostic instrument to detect
delirium, and even then, only 7% sometimes assessed for delirium using the instrument.
Therefore, implementing the CAM-ICU assessment in the ICU can improve delirium recognition
among ICU patients.
Purpose
According to Barr et al. (2013) the current evidence-based practice is to routinely monitor
patients for delirium using a standardized diagnostic tool in the ICU setting. The purpose of this
study was to implement delirium monitoring for ICU patients using a standardized diagnostic
tool in the surgical ICU. Adherence and incidence of CAM-positive patients will be measured
along with the type, route of administration, and frequency of sedative and analgesia medications
administered at 24, 48, 72, and 96-hours following admission. Currently, the University of
Louisville Hospital does not use a standard diagnostic tool to assess for delirium. For this study,
the nurses on the surgical ICU were educated on the CAM-ICU instrument for routine
monitoring of delirium among surgical ICU patients. The specific aims of this study were:
1) To provide nurses with a standardized delirium diagnostic tool to monitor for
delirium
2) To evaluate adherence to routine delirium after the introduction of the CAM-ICU
assessment
3) To evaluate the incidence of CAM-positive patients on the surgical ICU at 48 and 96
hours post admission
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4) To determine the type, route of administration, and frequency of sedative and
analgesic medications administered at 24, 48, 72, and 96 hours post admission.
Methods
Prior to the study beginning, approval was obtained from the University of Kentucky
Institutional Review Board (IRB) and the University of Louisville IRB. Authorization to conduct
the study on the surgical ICU was acquired from the clinical manager. This study was a singlecenter, post-implementation, retrospective descriptive medical record review examining the
impact of delirium monitoring, via the CAM-ICU tool, on patients admitted to the surgical ICU
at the University of Louisville Hospital. After education was given to the surgical ICU nurses on
how to assess for delirium using the CAM-ICU instrument, daily delirium assessments were
conducted on each patient admitted to the surgical ICU for a six week period. The following data
were collected during the six week study time frame: adherence to delirium monitoring through
documentation, incidence of CAM-positive patients, and sedation and analgesic medication
usage.
Setting
The University of Louisville Hospital is a level one academic medical center located in
downtown Louisville, Kentucky. This is a 404-bed acute care hospital that admits patients from
all over Kentucky and southern Indiana. The focus of this study was the ten-bed surgical ICU,
which typically treats surgical patients, i.e. vascular, colorectal, elective surgery, and surgical
oncology. Trauma patients are also commonly admitted to this ICU with injuries occurring from
gunshot wounds, motor vehicle accidents, motorcycle accidents, and falls. In addition to those
patients, this ICU admits overflow medical and neurosurgery ICU patients.
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Sample
This sample contained the medical records of 78 patients admitted to the surgical ICU
post implementation of the CAM-ICU assessment tool. Since delirium can affect any ICU
patient, the population of interest for this study was any ICU patients admitted to the surgical
ICU. Included in this study were: those patients, at least 18 years of age, who were admitted to
the surgical ICU between September 6, 2016 and October 18, 2016. Any patient under the age of
18 was excluded from the study. One patient was removed due to being under the age of 18 and
one was excluded due to being discharge from the surgical ICU on the day the study began,
resulting in a total of 76 patients in the sample.
Data Collection
After the six-week period was complete, a retrospective chart review was conducted.
Patients for the study were identified by electronically searching for patients admitted to the
surgical ICU on the study dates. The patients’ medical record numbers were then used to extract
data from the electronic medical record (EMR) and the data were then transposed into an
electronic spreadsheet. No patient identifiers were contained within this spreadsheet; all patients
were assigned numbers (1-76) for the protection of protected health information (PHI).
Demographic variables such as age, sex, race and admitting service were obtained from the data.
Implementation of Delirium Monitoring
One aim of this study was to implement routine delirium monitoring for ICU patients on
the surgical ICU at the University of Louisville Hospital. The week prior to the initiation of the
study, all of the surgical ICU nurses on both shifts were instructed by the principle investigator
(PI) on how to detect delirium using the CAM-ICU assessment tool. The EMR used by the
hospital allowed for documentation of the CAM-ICU assessment within the patient’s EMR. The
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nurses were instructed, by the PI, on where documentation of the daily delirium assessments
needed to be recorded. Signs were placed around the unit to remind the nurses to conduct a
delirium assessment once a shift, along with flowsheets on how to assess patients using the
CAM-ICU assessment. Delirium monitoring continued for the next six weeks once a shift (8 a.m.
and 8 p.m.) for all patients admitted to the surgical ICU (see figure 1 for CAM-ICU assessment
flowsheet).
Adherence to Delirium Monitoring
By reviewing the EMR the PI verified delirium monitoring occurred once a shift at the 48
and 96-hour post admission to the surgical ICU time intervals in all patients whose EMR were
reviewed. The data were broken down into four categories: documentation occurred twice in the
24-hour period within 48 and 96-hour following admission to the ICU, documentation only once
in a 24-hour period, no documentation of delirium assessment, or patient discharged prior to 48
or 96-hour evaluation. If the patient had a documented CAM-ICU assessment in the EMR at 8
a.m. and 8 p.m. in the 48 or 96-hour interval then the data was recorded as two out of two
assessments completed. If the patient only had one document CAM-ICU assessment in the EMR
at either 8 a.m. or 8 p.m. in the 48 or 96-hour interval then the data was recorded as one out of
two assessment completed. If the CAM-ICU assessment was not documented within the EMR at
8 a.m. and 8 p.m. in the 48 or 96-hour interval then the data was recorded as zero out of two
assessments completed. If the patient had been discharge prior to the 48 or 96-hour intervals then
it was recorded that the patient was not assessed using the CAM-ICU assessment due to the
patient being discharged from the surgical ICU.
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CAM-ICU Results
As with the adherence to delirium monitoring, the CAM-ICU results were measured at 48
and 96 hours post admission to the surgical ICU. CAM-ICU results required at least one
documented CAM-ICU assessment in the patients EMR at either 8 a.m. or 8 p.m. The data were
broken down into five categories: CAM-ICU negative, CAM-ICU positive, unable to assess, no
documentation completed, or discharged prior to evaluation. CAM-ICU negative are patients that
the CAM-ICU assessment determined that delirium was not present. These patients were
determined to be CAM-ICU negative at either the 48 or 96-hour interval by a documented CAMICU negative assessment in the EMR at 8 a.m. and/or 8 p.m. CAM-positive patients were
defined as a patient that tested positive for delirium using the CAM-ICU assessment at the 48 or
96-hour interval. These patients required CAM-ICU positive documentation in the EMR at 8
a.m. and/or 8 p.m. The unable to assess category occurred when the patient’s neurological status
was not suitable, either due to medications or injuries, to conduct the CAM-ICU assessment at
the 48 or 96-hour interval. The nurses determined if a patient was not suitable for the CAM-ICU
assessment using the CAM-ICU flowsheet; documentation that assessment was not appropriate
was required in the patient’s EMR at 8 a.m. and/or 8 p.m. to be included in the unable to assess
category. If documentation did not occur for the CAM-ICU assessment in the EMR at 8 a.m. or 8
p.m. in the 48 or 96-hour interval then the data was recorded as no CAM-ICU results. If the
patient had been discharge prior to the 48 or 96-hour intervals then it was recorded that the
patient was not assessed for delirium using the CAM-ICU assessment due to the patient being
discharged from the surgical ICU (see figure 1 for CAM-ICU assessment flowsheet).
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Administration of Sedation and/or Analgesic Medications
Sedative and analgesic medications were specifically reviewed. Pandharipande et al.
(2006) had found administering certain types of sedative and/or analgesic medication was
associated with the development of delirium. Sedatives are defined as medications that depress
central nervous activity, which reduces anxiety and induces sleep in patients. Typical sedative
medications used in the ICU patient are classified as benzodiazepines, but others such as general
anesthetics (Propofol) or alpha 2 adrenergic agonist (Precedex) can be administrated. Data were
collected on any benzodiazepine patients received along with continuous infusions of Propofol or
Precedex. Analgesics are defined as medications that provide relief from pain. Opioids, e.g.
Morphine, Fentanyl and Dilaudid, are common analgesic administrated to ICU patients.
Therefore, data were collected on any of these medications administered during the study. The
data collected on all these medications included the type, route of administration, and frequency.
Patients that were discharged prior to the 48-hour interval were excluded from this data
collection because they had been discharged prior to the initial evaluation time frame for
delirium using the CAM-ICU instrument. To determine the frequency of analgesic and/or
sedative administration, the data were divided into four post admission time frames: 24, 48, 72,
and 96 hours. From this a total number of dosages for analgesic and sedative medications for
each time frame were extrapolated from the EMR.
A comparison of the number of analgesic and/or sedative medications administered to
CAM-positive patients in relation to the CAM-negative patients was conducted. To compare the
data the average number of dosages for CAM-negative and CAM-positive patients at each time
frame was determined. Due to certain medications being linked to delirium the percentage of the
following medications administered to each group were collected: Fentanyl, Morphine, Versed,
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Ativan and Propofol (Pandharipande et al., 2006). For the purpose of this comparison CAMpositive patients were defined as a patient that tested positive for delirium at any point during the
96-hour time interval.
Data Analysis
Descriptive statistics, e.g. measures of central tendency and variability, were used to
analyze the data from this study. For adherence to delirium monitoring percentages were
determined for the number of patients that met the following categories: documentation occurred
twice in the 24-hour period within 48 and 96-hour following admission to the ICU,
documentation only once in a 24-hour period, no documentation of delirium assessment, or
patient discharged prior to 48 or 96-hour evaluation. CAM-ICU results were measured by the
percentages of patients that met each of the following categories: CAM-ICU negative, CAMICU positive, unable to assess, no documentation completed, or discharged prior to evaluation.
Administration of sedation and/or analgesic medications were measured using percentage, mean
and standard deviation.
Results
Sample Characteristics
A total of 76 patient EMRs were reviewed. The mean age of the patients in this study was
53.2 years old with males representing 56.6% (n=43) and females equaling 43.4% (n=33) of the
total sample. The racial breakdown of the study was: 79% Caucasian (n=60), 15.8% African
American (n=12), and 5.2% Other (n=4). The majority of patients (60.5%) on the surgical ICU
were admitted to the trauma service. The next most frequent admitting service was the medical
ICU (15.8%) and the neurosurgery service (11.8%) (see table 1 for the demographics of the
sample).

11

MONITORING FOR DELIRIUM IN THE INTENSIVE CARE UNIT
Adherence to Delirium Monitoring
Twenty-one (27.6%) of the 76 patients had been discharged from the surgical ICU prior
to the 48-hour evaluation. Therefore, 55 patients remained on the surgical ICU at the 48-hour
evaluation. Thirty-two (58.1%) of those patients had the CAM-ICU assessment completed twice
in the 48-hour period following admission. At the 96-hour evaluation, 28 (51%) had been
discharged from the surgical ICU, leaving 27 patients appropriate for data review. Of those, 22
(81.4%) patients had the CAM-ICU assessment completed twice during the 96-hour evaluation
(see table 2 for adherence to delirium monitoring).
CAM-ICU Results
At the 48-hour evaluation, 55 of the original 76 patients were still admitted to the surgical
ICU. Of those patients, 36 (65.5%) were determined to be CAM-ICU negative, while five (9%)
patients tested positive for delirium using the assessment tool. When the data were reviewed for
the 96-hour evaluation a total of 27 patients remained on the surgical ICU with 16 (59.2%)
patients being CAM-ICU negative. In addition, one (3.7%) patient was found to be CAM-ICU
positive at the 96-hour evaluation (see table 3 for CAM-ICU results).
Of the five patients who tested positive for delirium 48 hours post admission, one of
those patients tested positive again at the 96 hour interval. Of the other four CAM-positive
patients, one expired on the unit, two were determined to be CAM-ICU negative at the 96-hour
evaluation, and one was discharged prior to the 96 hour interval. The demographics of these
CAM-positive patients were: three female, two male, all Caucasian, two admitted to the trauma
service, two to the medical ICU, and one to neurosurgery.
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Administration of Sedation and/or Analgesic Medications
Twenty-one (27.6%) of the 76 patients had been discharged from the surgical ICU prior
to the 48-hour evaluation. Therefore, 55 patients remained on the surgical ICU at the 48-hour
evaluation. Six (10.9%) of the patients received no sedation or analgesic medication during the
time intervals examined and 49 (89%) patients received some type of sedative or analgesic
medication. The most common analgesics were intravenous Dilaudid and Morphine; both were
equally administered to 20 (36.3%) patients. Norco represented the most common oral analgesic
medication, being given to eighteen (32.7%) patients. Sedative medications were less frequently
administered when compared with analgesics, 16 (13.8%) versus 100 (86.2%) respectively.
Versed intravenous push was the most common sedative, with six (13.6%) patients receiving a
dose during the time interval. A total of 19 (34.5%) patients received a continuous infusion of
either an analgesic or sedative medication. The two most common continuous infusions
administrated were the analgesic Fentanyl to ten (18.2%) of the patients and the sedative Versed
to five (9%) of the patients. Excluding the continuous infusions, the majority medications
(84.6%) were prescribed as PRN doses giving the nurse the ability to choose the type and
number of times the medications were administrated. Of the total number of patients only 14
(25.5%) received a scheduled dose of an analgesic, no scheduled intravenous push or oral
sedatives were administered (see table 4 for a detailed breakdown of the types of medication
administered).
Overall, more dosages of analgesic medications were administered than sedative
medications, 579 dosages (83.5 %) versus 114 dosages (16.5%). For analgesics, the time frame
with the highest number of dosages was the 48-hour interval, with 173 (29.9%) dosages being
administered. The amount of analgesics administered decreased after the 48-hour interval.
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Sedative medications were administered the most during the 48-hour period, with 36 (31.6%)
dosages given (see figure 2 for a graph of total number of dosages overtime).
CAM-Negative versus CAM-Positive Patients
In this study 36 (65.5%) patients were determined to be CAM-ICU negative, while five
(9%) patients tested positive for delirium at the 48-hour evaluation using the assessment tool.
The results for CAM-negative patients were consistent with the findings described in the
previous section. The 48-hour time interval had the highest average number of dosages for
analgesic medications at 2.3 (29.4%). The average number of dosages decrease after the 48-hour
time interval. With regards to sedative medications and CAM-negative patients the highest
average number of dosages, 1.9 (30.2%), occurred at the 48-hour interval. Sedative medication
usage for this group remained comparatively low and consistent through the 96-hour time frame.
In terms of specific medications that are linked to delirium development, 25% of CAM-negative
patients received Fentanyl, 23.6% Morphine, 13.9% Versed, 5.6% Ativan and 8.3% Propofol
(see figure 3 for the comparison of analgesic medications: CAM-positive vs. CAM-negative).
CAM-positive patients’ results differed from CAM-negative patients. Their analgesic
medications usage increased progressively, peaking at the 72-hour interval with the average dose
at 3.6 (32.1%). The use of sedative medications peaked at the 24-hour interval then had a
decreased at the 48-hour time frame; after which sedative medication usage rose steadily from
the 48 through 96-hour interval. In terms of specific medications that are linked to delirium
development, 20% of CAM-positive patients received Fentanyl, 100% Morphine, 40% Versed,
20% Ativan and 0% Propofol (see figure 4 for the comparison of sedative medications: CAMpositive vs. CAM-negative).
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Discussion
The purpose of this study was to implement the evidence-based practice of routine
delirium monitoring in the surgical ICU. Current guidelines recommend delirium monitoring at
least once a shift (every twelve hours) for ICU patients using a valid standardized tool (Barr et
al., 2013; Pandharipande et al., 2005). The surgical ICU at the University of Louisville Hospital
was chosen to conduct this study because currently this hospital does not monitor patients for
delirium. It was determined that delirium assessment would occur at 8 a.m. and 8 p.m. for every
patient admitted to the surgical ICU using the CAM-ICU tool. Overall adherence to once a shift
delirium monitoring occurred 58.1% of the time at the 48-hour interval and 81.4% of the time for
the 96-hour interval. CAM-negative patients represented 65.5% and 59.2% of the patients at 48
and 96 hour intervals respectively. While CAM-positive patients made up only 9% of the
patients in the 48-hour interval and 3.7% in the 96-hour interval. Lastly, CAM-positive patients
received a higher number of sedatives when compared to CAM-negative patients.
Delirium Monitoring
A key factor to the improvement of delirium management and improvement in patient
outcomes is adherence to routine delirium monitoring of ICU patients for delirium
(Pandharipande et al., 2005). This study measured adherence to delirium monitoring and found
that, especially at the 48-hour interval, it was lacking at only 58.1%. This finding did not differ
from another study that looked at adherence to routine delirium monitoring. Devlin et al. (2008)
found that less than half of the ICU nurses surveyed perform regular delirium assessment even
though their hospital protocol expressly included routine delirium monitoring. A specific factor
that could explain why adherence was not higher during this study is because this ICU is
critically short staffed. This ICU must rely on staff from other ICUs and the critical care float
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pool to have an adequate number of staff during a shift. It was not feasible to provide these nonregular staff members with education on how and when to conduct the CAM-ICU assessment.
Therefore, these nurses could have skewed the results for adherence to delirium monitoring. This
failure to assess for delirium could have also altered the incidence of delirium in this study.
Roughly 40% of the patients at the 48-hour interval failed to have a delirium assessment
completed.
Incidence of Delirium
The incidence of delirium in this study was found to be low (9%), while current research
shows delirium to be much more prevalent, up to 80%, among ICU patients (Pandharipande et
al., 2005). Certain risk factors have been “positively and significantly associated with the
development of delirium in the ICU: preexisting dementia; history of hypertension and/or
alcoholism; and a high severity of illness” (Barr et al., 2013, p. 286). One of these risk factors
that could have been lower in the patients in the study was the acuity of the illness of these
patients. The severity of illness can be measured using the APACHE II. However, the admitting
services currently do not document the severity of illness using a scoring system, so no data was
able to be compiled. A comparison of this data would have led to a greater understanding if these
patients were at a lower risk for delirium than other ICU patients thus possibility explaining the
low incidence of delirium found.
Previous studies have shown that age is also a risk factor for the development of delirium
but the patients of this study were relativity young, with a mean age of 53.2 (Pandharipande et
al., 2006; Barr et al., 2013). Truman and Ely (2003) identified that with regards to age, over
seventy, place a patient at risk for the development of delirium. The younger age of this study’s
population could have decreased their risk factor for the development of delirium and thus the
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incidence of delirium in this study. When this relative young age was combined with the possible
decreased severity of illness, an overall decrease in risk for delirium could have existed among
these patients. These decreased risks could explain why this study had a lower prevalence of
delirium when compared with previous studies.
Sedatives/Analgesic and CAM-Positive Patients
Overall, the CAM-positive patients received a higher average number of dosages of both
analgesic and sedative medications when compared with the CAM-negative patients (see figure 3
for the comparison of analgesic medications: CAM-positive vs. CAM-negative and Figure 4 for
the comparison of sedative medications: CAM-positive vs. CAM-negative). Due to the small
sample size of CAM-positive patients a statistical inference could not be determined. However,
this finding was consistent with previous studies that found a statistical significant association
between sedative medications usage and an increased incidence of delirium (Barr et al., 2013;
Pandharipande et al., 2006). The increased analgesic mediations usage in delirium positive
patients was also consistent with previous studies, which found a correlation between those
medications and delirium (Barr et al., 2013; Pandharipande et al., 2006). Also noted within this
study was the under use of Precedex as an alternative to continuous benzodiazepine infusions,
1.8% versus 9% respectively. According to the current guidelines, Precedex is recommended
over the use of benzodiazepines in patients not suffering for alcohol withdrawal to decrease the
incidence of delirium in ICU patients (Barr et al., 2013).
Sedative and analgesic medications were mostly prescribed as PRN doses. Therefore, the
nurses were highly responsible for the amount of medications the patients received during the
time intervals. This ability of the nurse to influence the type and amount of medications given to
a patient could have implications in terms of the development of delirium. This study did not
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evaluate the surgical ICU nurses knowledge of delirium. However, a high possibility exists that
these nurses did not have an evidence-based understanding of delirium (recognition of risks and
prevention). Currently, staff development on delirium is not provided by the education
department at the hospital, nor has there been quality improvement initiatives on evidence-based
delirium guidelines. Devlin et al. (2008) found that nurses who do not routinely monitor for
delirium lack the following knowledge: “(1) delirium is an underdiagnosed problem in the ICU,
(2) patients with delirium are often hypoactive, (3) nondrug therapy should be generally
considered before antipsychotic therapy, and (4) delirium is often associated with fluctuating
signs and symptoms” (p. 563). This lack of knowledge could lead to failure to identify delirium,
especially hypoactive delirium; the over administering of medications known to increase risk of
and underuse of non-pharmacological interventions to prevent/treat delirium in ICU patients.
Limitations
Several limitations existed in this study. Generalization of the results from this study
cannot be made because this study was a single-center study. The data were obtained from a
retrospective chart review, which means the results of the study relied upon the accuracy of the
documentation. The accuracy of the data also relied on the ability of the surgical ICU nurses to
conduct the CAM-ICU assessment appropriately and adhere to evidence-based protocols. The
acuity of the patients in the study could not be compared because the providers do not document
the APACHE II score in their progress notes or in the history and physical. Data from all patients
that met the inclusion/exclusion criteria were included in the study, but the sample size was
small. Statistical inferences about the data could not be made as a result of the small sample size
of CAM-positive patients.
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Recommendations
Implications for Practice
An important implication for practice would be to develop a delirium protocol that
included identification of high risk patients, e.g. “preexisting dementia, history of hypertension
and/or alcoholism and a high severity of illness”, routine monitoring with the CAM-ICU tool
once a shift, notification of provider of CAM-ICU positive patients, and preventive measures
(Barr et al., 2013, p.286). Preventive measures would be early mobilization of patients, daily
sedation vacations, avoid administering continuous infusions of benzodiazepines and instead use
Precedex (with the exception of patients withdrawing from alcohol), and promotion of sleep
wake cycle (Barr et al., 2013). Provider notification is important because then “clinicians will be
able to address reversible causes of delirium and avoid initiating treatments for agitation known
to worsen delirium, e.g. benzodiazepines” (Devlin, Brummel, & Al-Qadheeb, 2012, p. 386).
Even though this study specifically focused on the ICU, any patients within the hospital can
experience delirium; estimating to occur in 60% of non-ICU patients when they have three or
more risk factors (Truman & Ely, 2003). Therefore, it would be important to include all patients
in the hospital in the delirium protocol. Implementing delirium monitoring for all patients could
lead to an improvement in identification and treatment of delirium.
Prior to this study the majority of the nurses had never used the CAM-ICU assessment
tool, with the expectations of the travel nurses that had monitored for delirium at other facilities.
Even though education was provided on how to use the tool appropriately, the likelihood that
some nurses did not accurately assess patients is a concern. Therefore, a practice implications
would be to provide all nurses with extensive education on how to perform the CAM-ICU
assessment. A study found that the best implementation of the CAM-ICU assessment resulted
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after extensive education was provided, as well as frequent reminders for the staff to evaluate
each patient for delirium and consistent evaluations on the ability of the nurses to implement the
tool (Devlin et al., 2012). This can be accomplished by having the nursing education department
adapt the CAM-ICU assessment education into their new hire nursing education class and
requiring current staff to attend an educational presentation during yearly competencies.
Along with the education on the CAM-ICU assessment the nurses need to be provided
with evidence-based education on delirium (Gusmao-Flores et al., 2012). Delirium needs to be
understood in terms of an acute cognitive dysfunction of the brain and should be given as high of
a priority as any other organ dysfunction, e.g. heart, kidney, or liver (Pandharipande et al., 2005).
A lack of knowledge about risk factors associated with delirium, among nurses, can further
increase its incidence among patients (Arend & Christensen, 2009; Pandharipande et al., 2005).
For example, in this study the nurses continued to administer medications known to exacerbate
delirium even after patients tested positive for delirium.
Implications for Future Inquiry
A Future study in the area of delirium needs to be on how to decrease the incidence
through non-pharmacologic preventive measures that specifically examine ICU patients that
experience delirium. The current research that is available on preventive measures for delirium,
with the exception of early mobilization, were conducted on non-ICU patients (Barr et al., 2013).
Therefore, these findings may not be transferable to ICU patients experiencing delirium (Barr et
al., 2013; Truman & Ely, 2003). Until more studies are conducted on non-pharmacologic
prevention measures for delirium in the ICU, evidence-based guidelines are limited.
Future research also needs to focus on evidence-based pharmacological treatment of
delirium in the ICU patient. Currently, there is a lack of randomized controlled trials (RCTs) that
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show a consistent way to treat delirium among ICU patients (Barr et al., 2013; Devlin & Skrobik,
2011). One small study found that quetiapine, an atypical antipsychotic, may reduce delirium in
ICU patients but more studies need to occur to confirm whether this finding is generalizable to
all ICU patients that experience delirium (Barr et al., 2013). Therefore, until more research is
available evidence-based guidelines for the pharmacological treatment of delirium is extremely
limited.
Conclusion
Required routine delirium monitoring should occur per evidence-based practice
guidelines. The incidence of delirium in this study was found to be low, at 9%, when compared
to previous studies on delirium. No statistically significant conclusions could be drawn from this
study. CAM-ICU positive patients received more sedative medications than CAM-negative
patients in this study. This finding is consistent with previous studies that linked administration
of sedative medications, specifically benzodiazepines, and the development of delirium
(Pandharipande et al., 2006; Robinson et al., 2008). The next step beyond this study is to
implement a set delirium protocol that will require routine delirium monitoring of patients,
institute preventive measures, and limit the use of delirium exacerbating medications. Future
studies will need to focus on prevention and treatment by non-pharmacological and
pharmacological means, specifically for ICU patients. In conclusion, this single study may have
found a low incidence of delirium among these specific ICU patients but many previous studies
have determined that the incidence of delirium is much higher.
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Table 1.
Demographics of Sample
Demographics of Sample
Age, years mean
Sex
Male
Female
Race
Caucasian
African American
Other
Admitting Service
Trauma
Medical ICU
Neurosurgery
Other

(n=76)
53.2
43 (56.6%)
33 (43.4%)
60 (79%)
12 (15.8%)
4 (5.2%)
46 (60.5%)
12 (15.8%)
9 (11.8%)
9 (11.8%)
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Table 2.
Adherence to Delirium Monitoring
Adherence to Delirium Monitoring

Discharged from ICU prior to 48 or 96
hour evaluation
Documented at 8am and 8pm
Documented only once
Not documented

26

48 hours
(n=76)
21 (27.6%)

96 hours
(n=55)
28 (51%)

(n=55)
32 (58.1%)
16 (29.1%)
7 (12.7%)

(n=27)
22 (81.4%)
3 (11.1%)
2 (7.4%)
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Table 3.
CAM-ICU Results
CAM-ICU Results

Discharged prior to
evaluation
Negative
Positive

48 hours post admission
(n=76)
21 (27.6%)

96 hours post admission
(n=55)
28 (51%)

(n=55)
36 (65.5%)
5 (9%)

(n=27)
16 (59.2%)
1 (3.7%)

Note. Two groups excluded from this table were: unable to assess (10.9% at 24-hours and 29.6%
at 96-hours) and no documentation completed (14.5% at 24-hours and 7.4% at 96-hours).
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Table 4.
Breakdown of Medication Administered
Breakdown of Medications Administered
Total Subjects
(n=55)
Analgesics
Opioids
11 (20%)
Percocet 5/325mg
Morphine
1 (1.8%)
Oral
20 (36.3%)
Intravenous
20 (36.3%)
Dilaudid
Fentanyl
6 (10.9%)
Intravenous Push
10 (18.2%)
Continuous
18 (32.7%)
Norco
13 (23.6%)
Oxycodone
1 (1.8%)
Roxicet
Sedatives
1 (1.8%)
Precedex Infusion
Ativan
2 (3.6%)
Oral
2 (3.6%)
Intravenous
3 (5.5%)
Propofol Infusion
Versed
6 (10.9%)
Intravenous Push
5 (9%)
Continuous
1 (1.8%)
Valium
Antipsychotic
1 (1.8%)
Haldol
6 (10.9%)
No Analgesics or Sedative
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Figure 1. CAM-Assessment Flowsheet.

29

MONITORING FOR DELIRIUM IN THE INTENSIVE CARE UNIT

Total Number of Dosages Administered
200
173

180

165

155

NUMBER OF DOSAGES

160
140
120
100

86

80
60

36

40
20

31

29

18

0
24 hours

48 hours

Total Analgesics Medicatoins

72 hours
Total Sedation Medications

Figure 2. Total Number of Dosages Administered (n=49).
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AVERAGE DOSE

Comparison Analgesic Medcations: CAMPositive vs CAM-Negative
4
3.5
3
2.5
2
1.5
1
0.5
0

24 hours

48 hours

72 hours

96 hours

CAM-Positive Average Analgesic
Medication Dosages

1.6

2.6

3.8

3.4

CAM-Negative Average Analgesic
Medication Dosages

1.8

2.3

2

1.7

Figure 3. Comparison Analgesic Medications: CAM-Positive vs. CAM-Negative.
Note. SD ± 0.1(24hr), 0.2(48hr), 0.9(72hr), 0.9(96hr). CAM-negative patients n=39. CAMpositive patients n=5. CAM-positive defined as any patient that tested positive for delirium at
any point during the 96-hour interval.

31

MONITORING FOR DELIRIUM IN THE INTENSIVE CARE UNIT

Comparison Sedative Medcations: CAM-Positive
vs CAM-Negative
AVERAGE DOSE

3.5
3
2.5
2
1.5
1
0.5
0

24 hours

48 hours

72 hours

96 hours

CAM-Positive Average Sedative
Medication Dosages

3

1.2

2

2.7

CAM-Negative Average Sedative
Medication Dosages

1.3

1.9

1.6

1.5

Figure 4. Comparison Sedative Medications: CAM-Positive vs. CAM-Negative.
Note. SD ± 0.9(24hr), 0.4(48hr), 0.2(72hr), 0.6(96hr). CAM-negative patients n=39. CAMpositive patients n=5. CAM-positive defined as any patient that tested positive for delirium at
any point during the 96-hour interval.
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